BOT · Botanix Pharmaceuticals Limited
0.011
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$35.90M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 27/10/2026 04:10:29 PM
Price Chart
Description
- All-Companies
- All-Consensus
- GROWTH AUS
- HALO Consensus Value
- HALO Ords
Key Fundamentals
EPS 3 yr Growth
307.60%
EBITDA Margin
-194.10%
Operating Cashflow
-$65m
Free Cash Flow Return
-72.10%
ROIC
-77.90%
Interest Coverage
-23.60
Quick Ratio
1.60
Performance
52 weeks range
Low 0.01 - 0.15
Trade Value (12mth)
AU$129,988.00
1 week
8.33%
1 month
-27.78%
YTD
-90.37%
1 year
-90%
All time high
163.33
Additional Data
Shares Outstanding (Fully Diluted)
2,386m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.52
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Weak
Balance Sheet
Strong
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
27 October 26ASXD | |
27 October 26ASXD | |
21 October 26ASXD | |
19 October 26ASXD | |
19 October 26ASXD |
Key Stakeholders
| Name | Title |
| Insignia Financial Ltd. | Holding Company |
| Matthew Callahan | Individual |
| Caperi Pty Ltd. | Private Company |
| UniSuper Ltd. | Private Company |
| Henry William Bosch | Individual |
